Simultaneous Pancreas-kidney Transplantation With Campath Protocol
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine and compare the efficacy of Campath-1H/Tacrolimus
versus ATG/Tacrolimus/MMF therapy in conjunction with initial short-term steroids in Type
1-diabetic patients undergoing simultaneous pancreas-kidney allograft transplantation as well
as to evaluate the safety of Campath-1H/Tacrolimus versus ATG/Tacrolimus/MMF in terms of
drug-related complications and immunosuppression-associated complications.